Clinical Trial Update: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sorafenib for metastatic, locally advanced, or recurrent sarcoma has completed and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Epithelioid Sarcoma
• Leiomyosarcoma
• Malignant Peripheral Nerve Sheath Tumor
• Soft Tissue Sarcoma
• Synovial Sarcoma
• Undifferentiated Pleomorphic Sarcoma
• Uterine Sarcoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Angiosarcoma, Adult Epithelioid Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-20